Skip to main content
OpenTrials

Clinical trial condition

Neovascular Age-related Macular Degeneration

Explore clinical trials studying Neovascular Age-related Macular Degeneration. Study availability and eligibility vary by location and protocol.

148 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Neovascular Age-related Macular Degeneration trial results

Active, Not Recruiting

A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

NCT06680817

Conditions
Diabetic Macular Edema, Neovascular Age-related Macular Degeneration
Locations
  • LKH-Univ.Klinikum Graz Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Kepler Universitätskliniken GmbH - Med Campus III Linz, Austria
  • Medizinische Universitat Wien Vienna, Austria
View all 59 locations
View Trial Details
Active, Not Recruiting

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

NCT05904028

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Kent W. Small, MD, AMC Glendale, California, United States
  • Loma Linda University Loma Linda, California, United States
  • East Bay Retina Consultants, Inc. Oakland, California, United States
  • Kaiser Permanente - Oakland Oakland, California, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

NCT05476926

Conditions
Branch Retinal Vein Occlusion, Cardiovascular Diseases, Central Retinal Vein Occlusion, +10 more
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • California Eye Specialists Medical group Inc. Pasadena, California, United States
  • Retinal Consultants Medical Group Sacramento, California, United States
  • Advanced Research Coral Springs, Florida, United States
View all 299 locations
View Trial Details
Active, Not Recruiting

Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)

NCT06439576

Conditions
Cardiovascular Diseases, Diabetic Macular Edema, Embolism and Thrombosis, +7 more
Locations
  • Joint Shantou International Eye Center Shantou, Guangdong, China
  • The First Affiliated Hospital of Henan UN of Science and Technology Luoyang, Henan, China
  • Taihe Hospital of Shiyan Shiyan, Hubei, China
  • Xuzhou No.1 Peoples Hospital Xuzhou, Jiangsu, China
View all 41 locations
View Trial Details
Active, Not Recruiting

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

NCT04704921

Conditions
AMD, CNV, Choroid Diseases, +18 more
Locations
  • Retinal Research Institute /ID# 256019 Phoenix, Arizona, United States
  • Barnet Dulaney Perkins Eye Center - Sun City /ID# 256055 Sun City, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 271290 Little Rock, Arkansas, United States
  • Retina Vitreous Assoc Med Grp /ID# 256299 Beverly Hills, California, United States
View all 89 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)

NCT06196840

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +2 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Zhejiang University Eye Hospital Hangzhou, Zhejiang, China
  • Peking Union Medical College Hospital Beijing, China
  • West China Hospital of Sichuan University Chengdu, China
View Trial Details
Active, Not Recruiting

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

NCT04645212

Conditions
Blindness, Choroid Diseases, Choroidal Neovascularization, +18 more
Locations
  • Adverum Clinical Site Bakersfield, California, United States
  • Adverum Clinical Site Beverly Hills, California, United States
  • Adverum Clinical Site Lakewood, Colorado, United States
  • Adverum Clinical Site Deerfield Beach, Florida, United States
View Trial Details
Active, Not Recruiting

A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

NCT06491914

Conditions
Diabetic Macular Edema, Neovascular Age-related Macular Degeneration
Locations
  • Win Retina - Arcadia Arcadia, California, United States
  • California Retina Consultants Bakersfield, California, United States
  • Retina Specialists of Beverly Hills Beverly Hills, California, United States
  • Salehi Retina Institute dba Retina Associates of Southern California Huntington Beach, California, United States
View all 54 locations
View Trial Details

Related conditions